- Home
- ANIX vs RFM Comparison
ANIX vs RFM Comparison
Compare ANIX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- RFM
- Stock Information
- Founded
- ANIX 1982
- RFM 2020
- Country
- ANIX United States
- RFM United States
- Employees
- ANIX N/A
- RFM N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- RFM Finance/Investors Services
- Sector
- ANIX Health Care
- RFM Finance
- Exchange
- ANIX Nasdaq
- RFM Nasdaq
- Market Cap
- ANIX 95.7M
- RFM 85.5M
- IPO Year
- ANIX 1987
- RFM N/A
- Fundamental
- Price
- ANIX $3.35
- RFM $14.25
- Analyst Decision
- ANIX Strong Buy
- RFM
- Analyst Count
- ANIX 3
- RFM 0
- Target Price
- ANIX $9.00
- RFM N/A
- AVG Volume (30 Days)
- ANIX 108.8K
- RFM 20.7K
- Earning Date
- ANIX 09-10-2025
- RFM 01-01-0001
- Dividend Yield
- ANIX N/A
- RFM 9.74%
- EPS Growth
- ANIX N/A
- RFM N/A
- EPS
- ANIX N/A
- RFM N/A
- Revenue
- ANIX N/A
- RFM N/A
- Revenue This Year
- ANIX N/A
- RFM N/A
- Revenue Next Year
- ANIX N/A
- RFM N/A
- P/E Ratio
- ANIX N/A
- RFM N/A
- Revenue Growth
- ANIX N/A
- RFM N/A
- 52 Week Low
- ANIX $2.07
- RFM $12.89
- 52 Week High
- ANIX $4.20
- RFM $16.41
- Technical
- Relative Strength Index (RSI)
- ANIX 59.63
- RFM 63.00
- Support Level
- ANIX $2.93
- RFM $14.21
- Resistance Level
- ANIX $3.09
- RFM $14.37
- Average True Range (ATR)
- ANIX 0.16
- RFM 0.11
- MACD
- ANIX 0.06
- RFM 0.04
- Stochastic Oscillator
- ANIX 62.69
- RFM 78.87
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.